LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film (OTF) drug delivery technology, today ...

The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

The collaboration leverages LTS's background in technology transfer, scale-up, and manufacturing, providing Nualtis with resources to scale their OTF products and deliver them to patients worldwide.

The Award Highlights the Promise of Exclusively Targeting Peripheral Opioid Receptors to Treat Chronic Pain Without the Risk of Addiction and DependenceSAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

Netpulse AG has rolled out its new AI-powered SEO and AI-integrated Google Ads services. This Swiss digital marketing agency ...

Rhode Island manufacturer’s latest environment monitoring solution recognized for exceptional simplicity, ease of use, and ...

All matters presented for shareholder approval were overwhelmingly approved TORONTO, ON / ACCESS Newswire / June 25, 2025 / ...

Client-Focused Strategist Elevated to Lead Key Dealership Partnerships SCOTTSDALE, AZ / ACCESS Newswire / June 25, 2025 / ...

TAMPA, FL / ACCESS Newswire / June 25, 2025 / Strategos Group is proud to announce the return of former Indiana ...